Skip to main content
Clean Science and Technology Limited logo

Clean Science and Technology Limited — Investor Relations & Filings

Ticker · CLEAN ISIN · INE227W01023 LEI · 335800ONLA5LRUZJZB84 BSE.NS Manufacturing
Open in API
Filings indexed 481 across all filing types
Latest filing 2022-09-29 Regulatory Filings
Country IN India
Listing BSE.NS CLEAN

About Clean Science and Technology Limited

https://cleanscience.co.in/

Clean Science and Technology Limited specializes in the development and manufacture of specialty chemicals using sustainable and eco-friendly catalytic processes. The company focuses on green chemistry to produce high-purity performance chemicals, pharmaceutical intermediates, and FMCG ingredients. Key products include Monomethyl Ether of Hydroquinone (MEHQ), Butylated Hydroxyanisole (BHA), Ascorbyl Palmitate, Guaiacol, and 4-Methoxy Acetophenone (4-MAP). These products serve diverse global applications in the food, pharmaceutical, and personal care sectors. The company leverages proprietary technology and atom-efficient manufacturing routes to minimize waste and environmental impact, establishing itself as a global leader in several niche chemical segments through cost-effective and innovative production methodologies.

Recent filings

Filing Released Lang Actions
Schedule of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) informing them about the schedule of investor meetings. It references compliance with SEBI Listing Regulations and explicitly states that no unpublished price sensitive information will be discussed. The content is an announcement of upcoming investor meetings rather than a financial report, earnings release, or detailed presentation. The document length is short (1747 characters) and it serves as a notification rather than a report or transcript. Therefore, it fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2022-09-29 English
General updates
Regulatory Filings
2022-09-27 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) informing them about the schedule of investor meetings. It references compliance with SEBI Listing Regulations and explicitly states it is an intimation of scheduled meetings with institutional investors. The content is an announcement of upcoming investor interactions, not a financial report, earnings release, or detailed presentation. The document length is short (1695 characters), and it does not contain financial data or detailed analysis. Therefore, it fits the category of a Regulatory Filing (RNS) as a general regulatory announcement under SEBI regulations, rather than an investor presentation or report publication.
2022-09-07 English
Disclosure of other UPSI/material event
Regulatory Filings
2022-09-05 English
Schedule of Analysts/Institutional Investor Meet/Con. Call
Investor Presentation Classification · 70% confidence The document text is very short (363 characters) and consists of a schedule of meetings between company representatives and institutional investors. It does not contain any financial data, report content, or detailed analysis. This type of document is typically an announcement or notice related to investor interactions or presentations. Given the content, it aligns best with an Investor Presentation (IP) category, as it relates to scheduled meetings likely for investor relations purposes. However, since it is only a schedule and not the presentation itself, it could also be considered a Regulatory Filing (RNS) as a fallback. But given the context and typical classification, Investor Presentation (IP) is the most appropriate classification with moderate confidence due to the limited content.
2022-08-24 English
ESOP/ESPS/SBEB Scheme
Share Issue/Capital Change Classification · 95% confidence The document contains detailed information about a share issuance under an Employee Stock Option Scheme, including filing dates, stock exchanges involved (BSE and NSE), number of shares issued, par value, ISIN number, exercise price, and premium per share. This indicates it is an announcement related to a capital change or share issue. The document length is 2152 characters, which is relatively short and focused on the share issuance details rather than a full financial report. Therefore, it fits best under the category of Share Issue/Capital Change (SHA).
2022-08-24 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.